Article Information
History
- March 14, 2020.
Article Versions
- You are currently viewing Version 1 of this article (March 14, 2020 - 16:06).
- Version 2 (March 20, 2020 - 16:27).
- Version 3 (March 27, 2020 - 08:54).
- Version 4 (April 6, 2020 - 09:36).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Alejandro Lopez-Rincon1,*,
- Alberto Tonda2,
- Lucero Mendoza-Maldonado3,
- Eric Claassen5,
- Johan Garssen1,4 and
- Aletta D. Kraneveld1
- 1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands
- 2UMR 518 MIA-Paris, c/o 113 rue Nationale, 75103, Paris, France
- 3Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Col. Independencia C.P. 44348 Guadalajara, Jalisco, Mexico
- 4Department Immunology, Danone Nutricia research, Uppsalalaan 12, 3584 CT Utrecht, the Netherlands
- 5Athena Institute, Vrije Universiteit, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
- ↵*Corresponding author; email: alejandro.lopezrn{at}hotmail.com
Posted March 14, 2020.
Accurate Identification of SARS-CoV-2 from Viral Genome Sequences using Deep Learning
